Literature DB >> 19685067

Subjective visual vertical during eccentric rotation in patients with vestibular neuritis.

Seok Min Hong1, Seung Geun Yeo, Jae Yong Byun, Moon Suh Park, Chan Hum Park, Jun Ho Lee.   

Abstract

The subjective visual vertical (SVV) is a useful tool to evaluate clinical manifestations of vestibular loss, but there have been normal variations of the SVV within 1 degrees -3 degrees , and over time, the absolute deviated degrees of SVV tilts decreases. We investigated SVV values in patients with vestibular neuritis (VN) during eccentric rotation, the method used to assess utricular function during stimulation of one labyrinth. And we performed SVV in the resting state and during eccentric rotation to the lesion side and the healthy side of 15 patients with VN and 20 normal subjects. No difference in the resting state SVV values was observed between the VN patients and the control group, but there were significant differences in SVV values between these two groups during eccentric rotation. Therefore, SVV during eccentric rotation allowed us to obtain information about unilateral vestibular loss that could not be found by conventional SVV in patients with VN. Thus, SVV during eccentric rotation might be a good tool to diagnose unilateral vestibular loss.

Entities:  

Mesh:

Year:  2009        PMID: 19685067     DOI: 10.1007/s00405-009-1064-y

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  16 in total

Review 1.  Molecular mechanisms of recovery from vestibular damage in mammals: recent advances.

Authors:  C L Darlington; P F Smith
Journal:  Prog Neurobiol       Date:  2000-10       Impact factor: 11.685

Review 2.  Vestibular compensation revisited.

Authors:  P P Vidal; C de Waele; N Vibert; M Mühlethaler
Journal:  Otolaryngol Head Neck Surg       Date:  1998-07       Impact factor: 3.497

3.  Deviation of the subjective vertical in long-standing unilateral vestibular loss.

Authors:  S Tabak; H Collewijn; L J Boumans
Journal:  Acta Otolaryngol       Date:  1997-01       Impact factor: 1.494

4.  The judgement of the visual vertical and horizontal with peripheral and central vestibular lesions.

Authors:  G Friedmann
Journal:  Brain       Date:  1970       Impact factor: 13.501

5.  The subjective horizontal at different angles of roll-tilt in patients with unilateral vestibular impairment.

Authors:  J Bergenius; A Tribukait; K Brantberg
Journal:  Brain Res Bull       Date:  1996       Impact factor: 4.077

6.  The subjective visual vertical as a clinical parameter of vestibular function in peripheral vestibular diseases.

Authors:  A Böhmer; J Rickenmann
Journal:  J Vestib Res       Date:  1995 Jan-Feb       Impact factor: 2.435

7.  The results of vestibular evoked myogenic potentials, with consideration of age-related changes, in vestibular neuritis, benign paroxysmal positional vertigo, and Meniere's disease.

Authors:  Seok Min Hong; Seung Geun Yeo; Sung Wan Kim; Chang Il Cha
Journal:  Acta Otolaryngol       Date:  2008-08       Impact factor: 1.494

8.  Pathological eye-head coordination in roll: tonic ocular tilt reaction in mesencephalic and medullary lesions.

Authors:  T Brandt; M Dieterich
Journal:  Brain       Date:  1987-06       Impact factor: 13.501

9.  Subjective visual vertical during eccentric rotation in patients with benign paroxysmal positional vertigo.

Authors:  Seok Min Hong; Moon Suh Park; Chang Il Cha; Chan Hum Park; Jun Ho Lee
Journal:  Otol Neurotol       Date:  2008-12       Impact factor: 2.311

10.  Otolith dysfunction in vestibular neuritis: recovery pattern and a predictor of symptom recovery.

Authors:  H-A Kim; J-H Hong; H Lee; H-A Yi; S-R Lee; S-Y Lee; B-C Jang; B-H Ahn; R W Baloh
Journal:  Neurology       Date:  2008-02-05       Impact factor: 9.910

View more
  1 in total

1.  Independent Measures of Utricular Function: Ocular Vestibular Evoked Myogenic Potentials Do Not Correlate With Subjective Visual Vertical or Fundus Photographic Binocular Cyclorotation.

Authors:  Sarah Hösli; Dominik Straumann
Journal:  Front Neurol       Date:  2021-04-14       Impact factor: 4.003

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.